Rigel Pharmaceuticals, Inc.
RIGL
$42.58
$1.794.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 17.29M | 8.65M | 268.07M | 27.90M | 59.61M |
| Total Depreciation and Amortization | 848.00K | 597.00K | 601.00K | 603.00K | 607.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.23M | 5.86M | -243.35M | 2.90M | -36.96M |
| Change in Net Operating Assets | 286.00K | -12.39M | -3.34M | -7.37M | 7.27M |
| Cash from Operations | 30.65M | 2.73M | 21.98M | 24.03M | 30.54M |
| Capital Expenditure | -- | -- | 12.00K | -12.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.45M | -7.98M | -25.37M | -33.16M | -23.28M |
| Cash from Investing | 17.45M | -7.98M | -25.36M | -33.18M | -23.28M |
| Total Debt Issued | 40.00M | -- | -- | -- | -- |
| Total Debt Repaid | -47.75M | -7.50M | -7.50M | -- | -- |
| Issuance of Common Stock | 1.86M | 321.00K | 2.93M | 4.27M | 418.00K |
| Repurchase of Common Stock | -511.00K | -3.74M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.30M | -- | -- | -- | -- |
| Cash from Financing | -11.70M | -10.92M | -4.57M | 4.27M | 418.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.41M | -16.17M | -7.95M | -4.87M | 7.68M |